Avastin May Help Boost Survival With Aggressive Cervical Cancer: Study

This news article has expired. Below you will find a short description about the news article and comments that were left by CancerCompass users.

Women taking the drug lived more than 3 months longer on average, but side effects were an issue



You must be logged in to post comments.

We care about your feedback. Let us know how we can improve your CancerCompass experience.